Shares in the South African giant Mediclinic briefly fell last Friday on news that sales growth would be slower than expected in the group’s Middle East division. Mediclinic International, which comprises recent acquisition Al Noor and pre-existing Mediclinic facilities, has suffered from a co-payment introduced by the state insurer, staff shortages and regulatory delays.